Mount Yale Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664 | Buy |
+8
| New | +$664 | ﹤0.01% | 1406 |
|
|
2024
Q4 | – | Sell |
-2,842
| Closed | -$281K | – | 608 |
|
|
2024
Q3 | $281K | Buy |
2,842
+315
| +12% | +$31.1K | 0.03% | 459 |
|
|
2024
Q2 | $234K | Sell |
2,527
-80
| -3% | -$7.42K | 0.02% | 493 |
|
|
2024
Q1 | $247K | Sell |
2,607
-52
| -2% | -$4.93K | 0.02% | 488 |
|
|
2023
Q4 | $237K | Buy |
+2,659
| New | +$237K | 0.02% | 451 |
|
|
2023
Q3 | – | Sell |
-2,733
| Closed | -$227K | – | 513 |
|
|
2023
Q2 | $227K | Sell |
2,733
-237
| -8% | -$19.7K | 0.02% | 442 |
|
|
2023
Q1 | $226K | Buy |
+2,970
| New | +$226K | 0.03% | 438 |
|
|
2018
Q4 | – | Sell |
-857
| Closed | -$73K | – | 795 |
|
|
2018
Q3 | $73K | Buy |
857
+57
| +7% | +$4.86K | 0.01% | 532 |
|
|
2018
Q2 | $76K | Buy |
+800
| New | +$76K | 0.01% | 544 |
|